4 cancer drugs in shortage: When drugmakers expect supply to rebound

Drugmakers have pushed back their resupply estimates for carboplatin, one of four chemotherapy drugs in a monthslong shortage, with some formulations now not expected to return until 2027. Cisplatin, carboplatin, oxaliplatin and ifosfamide, which form the backbone of treatment for breast, lung, ovarian, testicular, bladder, and head and neck cancers, remain in active shortage, according […] The post 4 cancer drugs in shortage: When drugmakers expect supply to rebound appeared first on Beck...